How much does Pitobrutinib targeted drug cost?

Pitobrutinib is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma after at least two systemic therapies, includingBTK inhibitors. This drug effectively blocks the proliferation and survival signals of cancer cells by inhibiting specific tyrosine kinases in the B cell receptor signaling pathway, thereby significantly inhibiting the growth and spread of tumors. In clinical trials, pitobrutinib demonstrated excellent efficacy and safety, greatly improving patients' quality of life.

Common side effects include digestive discomfort such as nausea and vomiting, as well as symptoms such as fatigue and musculoskeletal pain. In addition, patients may also experience skin reactions such as rash, itching, difficulty breathing, pneumonia and other serious adverse reactions. Therefore, you should strictly follow medical instructions during use and pay attention to the monitoring and management of side effects.

Concerning the dosage of pitobrutinib, the recommended dose is generally 200 mg orally once daily until disease progression or unacceptable toxicity occurs. For special populations such as patients with severe renal impairment, the dose may need to be adjusted accordingly. At the same time, when pitobrutinib is combined with certain drugs such as strong CYP3A inhibitors, the dose may also need to be adjusted to avoid potential drug interactions.

In general, as a new type of lymphoma treatment drug, pitobrutinib may bring some side effects, but its performance in controlling disease progression and improving patients' quality of life is remarkable, providing a new treatment option for lymphoma patients.

Pitobrutinib has not yet entered the domestic market. Domestic patients in need need to go abroad or contact regular overseas medical consulting companies to purchase it. It is understood that there are two original and generic versions of Pitobrutinib in overseas markets. Taking the US market as an example, the price of the original version of 50mg*30 tablets is about 100,000 yuan, while the price of the generic version in Laos is about 4,500 yuan. For more information about pitobrutinib, please consult a professional overseas consulting company.

xa0

Reference: https://www.drugs.com/pirtobrutinib.html